| BAXTYMA AstraZeneca Ireland Limited
2356982 21 Oct 2024 | on 21 Oct 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines | |